It has been known for many years that the administration of endotoxin to either experimental animals or humans induces a state of resistance to the toxic effects of subsequent doses (8, 13) . The mechanisms underlying the development of early vs. late resistance (tolerance) appear to be distinct, since considerable evidence supports the view that a macrophage refractory state is important in early tolerance, whereas the appearance of anti-endotoxin antibodies mediates late tolerance (8, 11) . The evidence that late tolerance is mediated by antibody comes from studies which demonstrate that it: (i) is delayed in its appearance and persists for weeks or months; (ii) is relatively specific for the endotoxin initially administered; (iii) is transferred with the immunoglobulin G and immunoglobulin M fractions of immune sera; and (iv) is accelerated in its development in a preimmunized host (8) (9) (10) (11) 14) .
To study the role of protective antibodies in the lethal effects of endotoxin in mice, we have administered sublethal doses of purified preparations of bacterial lipopolysaccharide (LPS) to the F1 progeny of CBA/N mice. Male and female mice of this inbred strain and F1 male mice derived from CBA/N females are unable to form antibody to LPS (2, 24 A modification of the procedure of Rudbach et al. (19) was used to coat sheep erythrocytes (SRBC) with E. coli LPS. A 10-mg portion of E. coli LPS was added to 10 ml of 0.1 M phosphate buffer (pH 7.4) and placed in a boiling water bath for 150 min. A 5-ml amount of this solution was diluted to 50 ml with 0.9 M saline, and 1.25 ml of twice-washed (in saline), packed SRBC was added. This suspension was incubated at 37°C for 30 min, and the E. coli LPS-coated SRBC (LPS-SRBC) were washed three times in saline and resuspended in 10 ml of saline containing 1 mg of bovine serum albumin per ml.
A 100-pl portion of packed LPS-SRBC was diluted to 10 ml in bovine serum albumin saline, and 25,ul of this suspension was added to wells of a microtiter tray; 25 M1 of serial dilutions of individual sera was added to the wells, the microtiter plates were shaken, and the LPS-SRBC were allowed to settle at room temperature for 1 h. The highest titer of sera which caused agglutination of the LPS-SRBC was determined, the plates were centrifuged at 500 rpm for 5 min, and the supernatant was discarded. The LPS-SRBC were resuspended in 25 ,ul of bovine serum albumin saline by gentle agitation on a Vortex mixer, and 25 Ml of a 1: 1,000 dilution of a polyspecific goat anti-mouse immunoglobulin (Meloy Laboratories, Springfield, Va.) was added to each well to enhance the agglutination reaction. This amount of the goat anti-mouse immunoglobulin was chosen after it was shown that it produced the greatest enhancement using F1 female sera and LPS-SRBC. In the case of the F1 male sera this dilution of the goat antisera and a range of others 1:10 to 1:1,500 failed to enhance. In other experiments a 1: 1,000 dilution of the goat anti-mouse immunoglobulin optimally enhanced sera from F1 males immunized and tested against SRBC. After the anti-mouse immunoglobulin was added the LPS-SRBC were allowed to settle for 1 h, and the highest titer of sera at which the enhanced agglutination occurred was determined. Controls consisting of SRBC and trinitrophenol-coupled SRBC (TNP-SRBC) (16) were also tested in each experiment. No agglutination (either enhanced or unenhanced) was observed with either SRBC or TNP-SRBC.
Serum transfers. F. mice of either sex were bled through the tail vein 10 days after they received 100
Iug of E. coli LPS by i.p. inoculation. The sera from these bleeds were pooled and given in different amounts to groups of F1 female mice by i.v. injection 24 h before challenge with varying amounts of E. coli endotoxin.
RESULTS
Groups of 30 (CBA/N x DBA/2) F1 male or female mice were given 100, 200, or 400 ,ig of E. coli endotoxin i.p., and deaths were recorded over a period of 72 h. As shown in Table 1 , all mice (both males and females) that received 400
Iug of E. coli endotoxin by i.p. injection were dead within 72 h, and equivalent numbers of F1 males and F1 females died after receiving 200 ,Ig.
No deaths were observed when 100 ,ug of E. coli endotoxin was administered. These data demonstrate that the X-linked B-lymphocyte defect of (CBA/N x DBA/2) F1 male mice does not influence their resistance to the lethal effects of endotoxin.
The anti-LPS antibody responses of (CBA/N x DBA/2) F1 male and female mice were analyzed by immunizing with 100 ,ug of E. coli LPS, a nonlethal dose which in preliminary experiments protected F1 female mice from a subsequent challenge with 800 ,ug of E. coli endotoxin.
As shown in Table 2 , all F1 female mice formed antibody to this amount of LPS, with a response which reached a maximum at 10 days (mean reciprocal enhanced hemagglutination titer of >10,240). By contrast, none of 40 F1 male mice made detectable responses.
Having established the pattern of anti-LPS antibody production in (CBA/N x DBA/2) F1 male and female mice, we administered 100 jIg of E. coli LPS by i.p. or i.v. inoculation to groups of F1 male and female mice, waited 10 days, and challenged them with 800 jig ofE. coli endotoxin. As shown in Table 3 , the protection induced by 100 jig of E. coli LPS given i.p. or i.v. against the lethal effects of E. coli endotoxin was equivalent in immune-defective F1 males and their immunologically normal F1 female littermates. The possible protective effects of sera derived from F1 female or male mice that had received 100 Mg of E. coli LPS 10 days previously were tested by giving 10, 25, 50, 100, or 500 yl of F1 male or female immune sera to F1 female mice. On the following day the F1 female mice were challenged with 800 Mug of E. coli endotoxin. The pooled enhanced anti-LPS titers of the F1 female mice that received 500 1d of immune sera 16 h previously were 1:2,560. As shown in Table 4 , neither the F1 male or female sera protected F1 female mice against challenge with 800 ,g of E.
coli endotoxin.
DISCUSSION
Resistance to a number of the toxic effects of bacterial endotoxins can be induced in experimental animals by the administration of sublethal amounts of LPS. This phenomenon, which has been referred to as "tolerance," has been studied extensively in both humans and rabbits (8, (10) (11) (12) (13) (14) . Early studies suggested that resistance to the toxic effects of homologous and heterologous endotoxins was the result of enhanced reticuloendothelial activity (4, 5, 9) . However, subsequent passive transfer studies have demonstrated a protective role of antiserum directed against the O-specific antigens of endotoxins in endotoxin-induced toxicity (8) . In addition, studies in humans have shown that increases in anti-O antibody were associated with the late phase of tolerance. The loss of specificity when rough mutants were used to induce late tolerance suggested that common core antigens were also capable of inducing late tolerance. However, it has not been definitively shown that anti-O-specific or common core antibodies were responsible for late tolerance, since the protective effects of passively transferred sera were not shown to be eliminated by absorption with either anti-immunoglobulins or LPS.
We have utilized CBA/N mice to study the role of anti-endotoxin antibodies in the development of tolerance to the lethal effects of endotoxin. CBA/N mice have an X-linked defect in B-lymphocyte function which influences a number of their immune functions (1, 2, 15, 21-23 ). It has previously been shown that mice that express the CBA/N immune defect respond normally to the macrophage-and lymphocyte-activating effects of LPS and that they can mount a specific thymic-independent TNP response to 0/5 a Sera were derived from F, male or female mice that were immunized with 100 pg of E. coli LPS administered by i.p. inoculation 10 days previously. The reciprocal hemagglutination titer of these pooled sera were >10,240 and 0 for the females and males, respectively.
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Boivin preparations of TNP-endotoxin (2, 15, 18, 21) . However, recent studies have indicated that these mice are unable to respond with specific antibody to protein-depleted preparations of E. coli LPS (24; Zaldivar and Scher, Abstr. Annu. Meet. Am. Soc. Microbiol. 1977, B77, p. 28). In this report, antibody formation was assayed by an enhanced hemagglutination technique. This procedure detected anti-LPS and not anti-SRBC antibodies, since agglutination was not observed when preimmune sera were tested with LPS-SRBC or when high-titer anti-LPS sera were tested with SRBC. Analysis of sera derived from (CBA/N x DBA/2) F1 male mice after immunization with a purified preparation ofLPS (derived from E. coli) demonstrated that these immune-defective mice were unable to form anti-LPS antibody to this preparation. In spite of this unresponsiveness, (CBA/N x DBA/2) F1 male mice were no more susceptible to the lethal effects of E. coli endotoxin than their immunologically normal F1 female littermates. These findings are quite distinct from those observed with C3H/HeJ mice, a strain which is also unable to form anti-LPS antibody and is highly resistant to the toxic actions of LPS (25, 26) . These findings are reminiscent of the contrasting mitogenic, adjuvant, and lymphocyte-macrophage-activating actions of LPS in these two strains since C3H/HeJ mice are resistant to these effects, whereas (CBA/N x DBA/2) F1 male mice are not (6, 7, 17, 18) . Thus, the lethal effects of endotoxin appear to be correlated with its nonspecific biological properties, but not with its immunogenicity in C3H/HeJ and (CBA/N x DBA/2) F1 male mice.
The equivalent sensitivity of (CBA/ x DBA/ female and male 10-day sera to confer resistance in passive transfer experiments.
These transfer experiments did not influence the toxicity of 800 ,ug of endotoxin in spite of a titer of 1:2,560 in mice that received 500,ul of F1 female sera 16 h previously. Thus, neither F1 female or male sera afforded protection. It should be emphasized that these experiments do not by themselves indicate that passively transferred sera could not under different experimental conditions induce protection, particularly in view of the fact that we utilized only one dose of endotoxin for challenge. With lower doses of endotoxin, it is entirely possible that sera from tolerant animals could be protective. However, these findings, along with the excellent protection observed in F1 male mice that had no detectable anti-LPS antibodies, strongly suggest that factors other than antibody play a critical role in the development of tolerance to the lethal effects of endotoxin and that anti-LPS antibody is not necessary for the development of resistance to an 800-,ug challenge of endotoxin in F, male mice.
The ability of (CBA/N x DBA/2) F1 male mice to respond to certain of the immune effects of LPS, as noted above, may provide insights into the mechanisms involved in this phenomenon. Certainly, analysis of LPS-induced resistance in these mice, where anti-LPS antibody is not formed, will be useful as an experimental model to analyze the multiple biological effects of LPS.
